• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HL-60细胞免疫逃逸的表观遗传修饰及其机制的初步研究

Epigenetic modification and preliminary investigation of the mechanism of the immune evasion of HL-60 cells.

作者信息

Liu Jin Hong, Bian Yong Mei, Xie Yi, Lu Dao Pei

机构信息

Department of Hematology, The Fifth People's Hospital of Shanghai, Fudan University, Shanghai 200240, P.R. China.

Department of Pediatrics, Minhang District Maternal and Child Health Care Hospital of Shanghai, Shanghai 201102, P.R. China.

出版信息

Mol Med Rep. 2015 Jul;12(1):1059-65. doi: 10.3892/mmr.2015.3526. Epub 2015 Mar 20.

DOI:10.3892/mmr.2015.3526
PMID:25815463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4438930/
Abstract

The aim of the present study was to explore the effect of epigenetic modification of class II transactivator (CIITA) methylation on histocompatibility complex (MHC) class II expression and the immune evasion of leukemia HL-60 cells. HL-60 cells were treated with various concentrations of 5-aza-2'deoxycytidine (5-Aza-CdR) and 0.5 µmol/l suberoylanilide hydroxamic acid (SAHA) for 24 h and then stimulated by interferon γ (IFN-γ) for 48 h. The mRNA levels of MHC class I, II and co-stimulatory molecules were quantified by reverse transcription polymerase chain reaction (RT-PCR). The levels of CIITA protein were determined by western blot analysis, and the CpG island methylation ratios in the CIITA promoter IV (CIITApIV) were analyzed by bisulfite-sequencing PCR (BSP). MHC I as well as the co-stimulatory molecules CD40 and CD80 were significantly increased following treatment with 5-Aza-CdR + SAHA + IFN-γ (epigenetic groups) compared with those in the control group and IFN-γ group (P<0.05). The expression of MHC class II and CIITA was restored and increased in an 5-Aza-CdR concentration-dependent manner in the three epigenetic groups. The results of the BSP assay showed that the methylation rate of CIITApIV CpG sites decreased with the treatment of epigenetic modification and negatively correlated to the 5-Aza-CdR concentration. This demonstrated that the negative expression of CIITA protein was the key reason for the loss of MHC II expression in HL-60 cells. The results of the present study may help to illustrate the mechanism of immune evasion in HL-60 cells.

摘要

本研究的目的是探讨II类反式激活因子(CIITA)甲基化的表观遗传修饰对白血病HL-60细胞的组织相容性复合体(MHC)II类表达及免疫逃逸的影响。用不同浓度的5-氮杂-2'-脱氧胞苷(5-Aza-CdR)和0.5 μmol/l的辛二酰苯胺异羟肟酸(SAHA)处理HL-60细胞24小时,然后用干扰素γ(IFN-γ)刺激48小时。通过逆转录聚合酶链反应(RT-PCR)定量MHC I类、II类及共刺激分子的mRNA水平。通过蛋白质免疫印迹分析测定CIITA蛋白水平,并通过亚硫酸氢盐测序PCR(BSP)分析CIITA启动子IV(CIITApIV)中的CpG岛甲基化率。与对照组和IFN-γ组相比,5-Aza-CdR + SAHA + IFN-γ处理组(表观遗传组)的MHC I以及共刺激分子CD40和CD80显著增加(P<0.05)。在三个表观遗传组中,MHC II类和CIITA的表达以5-Aza-CdR浓度依赖性方式恢复并增加。BSP分析结果显示,CIITApIV CpG位点的甲基化率随着表观遗传修饰处理而降低,且与5-Aza-CdR浓度呈负相关。这表明CIITA蛋白的阴性表达是HL-60细胞中MHC II表达缺失的关键原因。本研究结果可能有助于阐明HL-60细胞免疫逃逸的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5d0/4438930/9d7c8b6a54f4/MMR-12-01-1059-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5d0/4438930/e85a55ac5664/MMR-12-01-1059-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5d0/4438930/5463d37efa4d/MMR-12-01-1059-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5d0/4438930/acfe5409eaee/MMR-12-01-1059-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5d0/4438930/112cf87a6e25/MMR-12-01-1059-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5d0/4438930/9d7c8b6a54f4/MMR-12-01-1059-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5d0/4438930/e85a55ac5664/MMR-12-01-1059-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5d0/4438930/5463d37efa4d/MMR-12-01-1059-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5d0/4438930/acfe5409eaee/MMR-12-01-1059-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5d0/4438930/112cf87a6e25/MMR-12-01-1059-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5d0/4438930/9d7c8b6a54f4/MMR-12-01-1059-g04.jpg

相似文献

1
Epigenetic modification and preliminary investigation of the mechanism of the immune evasion of HL-60 cells.HL-60细胞免疫逃逸的表观遗传修饰及其机制的初步研究
Mol Med Rep. 2015 Jul;12(1):1059-65. doi: 10.3892/mmr.2015.3526. Epub 2015 Mar 20.
2
Methylation of class II trans-activator promoter IV: a novel mechanism of MHC class II gene control.II类反式激活因子启动子IV的甲基化:MHC II类基因调控的新机制。
J Immunol. 2000 Apr 15;164(8):4143-9. doi: 10.4049/jimmunol.164.8.4143.
3
Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts.II类反式激活因子(CIITA)启动子甲基化与滋养层细胞中CIITA转录沉默不相关。
Biol Reprod. 2003 Sep;69(3):915-24. doi: 10.1095/biolreprod.103.017103. Epub 2003 May 14.
4
Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.II类反式激活因子(CIITA)的表观遗传失活与结肠直肠癌和胃癌细胞中干扰素-γ诱导的HLA-DR表达缺失有关。
Oncogene. 2004 Nov 25;23(55):8876-86. doi: 10.1038/sj.onc.1208144.
5
Lack of IFN-gamma-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines.通过启动子甲基化导致的II类反式激活因子(CIITA)缺乏IFN-γ介导的诱导主要见于发育性肿瘤细胞系。
Int J Cancer. 2002 Feb 1;97(4):501-7. doi: 10.1002/ijc.1623.
6
Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma.II类主要组织相容性复合体反式激活因子(CIITA)IV型启动子在B淋巴细胞中的表达及γ干扰素对其的调控
Mol Immunol. 2006 Feb;43(6):519-28. doi: 10.1016/j.molimm.2005.05.005. Epub 2005 Jun 13.
7
Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells.造血肿瘤细胞中,DNA甲基化和组蛋白去乙酰化导致II类反式激活因子失活,这与γ干扰素诱导HLA-DR缺失相关。
Br J Cancer. 2004 Feb 23;90(4):844-52. doi: 10.1038/sj.bjc.6601602.
8
Methylation of CIITA promoter IV causes loss of HLA-II inducibility by IFN-gamma in promyelocytic cells.CIITA启动子IV的甲基化导致早幼粒细胞中HLA-II对IFN-γ诱导性的丧失。
Int Immunol. 2008 Nov;20(11):1457-66. doi: 10.1093/intimm/dxn103. Epub 2008 Oct 1.
9
Nitric oxide and KLF4 protein epigenetically modify class II transactivator to repress major histocompatibility complex II expression during Mycobacterium bovis bacillus Calmette-Guerin infection.一氧化氮和 KLF4 蛋白通过表观遗传修饰 II 类转录激活子,抑制牛分枝杆菌卡介苗感染期间主要组织相容性复合体 II 的表达。
J Biol Chem. 2013 Jul 12;288(28):20592-606. doi: 10.1074/jbc.M113.472183. Epub 2013 Jun 3.
10
Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator.葡萄膜黑色素瘤细胞中MHC II类基因表达的抑制是由于CIITA基因或上游激活剂的甲基化。
Exp Mol Pathol. 2007 Feb;82(1):68-76. doi: 10.1016/j.yexmp.2006.03.005. Epub 2006 May 2.

引用本文的文献

1
Epigenetic regulation of major histocompatibility complexes in gastrointestinal malignancies and the potential for clinical interception.胃肠道恶性肿瘤中主要组织相容性复合物的表观遗传调控及其临床干预的可能性。
Clin Epigenetics. 2024 Jun 24;16(1):83. doi: 10.1186/s13148-024-01698-8.

本文引用的文献

1
Epigenetic modifications in pediatric acute lymphoblastic leukemia.儿科急性淋巴细胞白血病的表观遗传学修饰。
Front Pediatr. 2014 May 14;2:42. doi: 10.3389/fped.2014.00042. eCollection 2014.
2
Validation of DNA methylation biomarkers for diagnosis of acute lymphoblastic leukemia.验证用于诊断急性淋巴细胞白血病的 DNA 甲基化生物标志物。
Clin Chem. 2014 Jul;60(7):995-1003. doi: 10.1373/clinchem.2013.219956. Epub 2014 May 14.
3
Epigenetic and molecular mechanisms underlying the antileukemic activity of the histone deacetylase inhibitor belinostat in human acute promyelocytic leukemia cells.
组蛋白去乙酰化酶抑制剂贝利司他在人急性早幼粒细胞白血病细胞中的抗白血病活性的表观遗传和分子机制。
Anticancer Drugs. 2014 Sep;25(8):938-49. doi: 10.1097/CAD.0000000000000122.
4
The link between MHC class I abnormalities of tumors, oncogenes, tumor suppressor genes, and transcription factors.肿瘤 MHC I 类分子异常与癌基因、抑癌基因和转录因子之间的联系。
J Immunotoxicol. 2014 Oct;11(4):308-10. doi: 10.3109/1547691X.2013.875084. Epub 2014 Jan 30.
5
Immune escape from NY-ESO-1-specific T-cell therapy via loss of heterozygosity in the MHC.通过 MHC 杂合性丢失实现针对 NY-ESO-1 的 T 细胞免疫逃逸。
Gene Ther. 2014 Mar;21(3):337-42. doi: 10.1038/gt.2013.87. Epub 2014 Jan 23.
6
CIITA and Its Dual Roles in MHC Gene Transcription.CIITA 及其在 MHC 基因转录中的双重作用。
Front Immunol. 2013 Dec 20;4:476. doi: 10.3389/fimmu.2013.00476.
7
Contrasting effects of IFNα on MHC class II expression in professional vs. nonprofessional APCs: Role of CIITA type IV promoter.干扰素α对专职与非专职抗原呈递细胞中MHC II类分子表达的不同影响:CIITA IV型启动子的作用
Results Immunol. 2012 Sep 27;2:174-83. doi: 10.1016/j.rinim.2012.09.001. eCollection 2012.
8
Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia.儿童急性淋巴细胞白血病中DNA甲基化差异的全基因组特征
Genome Biol. 2013 Sep 24;14(9):r105. doi: 10.1186/gb-2013-14-9-r105.
9
Histone deacetylase inhibitors activate CIITA and MHC class II antigen expression in diffuse large B-cell lymphoma.组蛋白去乙酰化酶抑制剂激活弥漫性大 B 细胞淋巴瘤中的 CIITA 和 MHC Ⅱ类抗原的表达。
Immunology. 2013 Oct;140(2):259-72. doi: 10.1111/imm.12136.
10
Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancer.恶魔面部肿瘤病通过 MHC 分子的可逆表观遗传下调表明传染性癌症的免疫逃避。
Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5103-8. doi: 10.1073/pnas.1219920110. Epub 2013 Mar 11.